Patents by Inventor Steven Craig Ghivizzani

Steven Craig Ghivizzani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220333051
    Abstract: A three-dimensional cell growth medium is described. The cell growth medium may comprise hydrogel particles swollen with a liquid cell growth medium to form a granular gel yield stress material which undergoes a phase transformation from a solid phase to a liquid-like phase when an applied stress exceeds the yield stress. Cells may be placed in the three-dimensional cell growth medium according to any shape or geometry, and may remain in place within the three-dimensional cell growth medium.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 20, 2022
    Inventors: WALLACE GREGORY SAWYER, THOMAS ETTOR ANGELINI, STEVEN CRAIG GHIVIZZANI, TAPOMOY BHATTACHARJEE, GLYN DANIEL PALMER
  • Patent number: 11390835
    Abstract: A three-dimensional cell growth medium is described. The cell growth medium may comprise hydrogel particles swollen with a liquid cell growth medium to form a granular gel yield stress material which undergoes a phase transformation from a solid phase to a liquid-like phase when an applied stress exceeds the yield stress. Cells may be placed in the three-dimensional cell growth medium according to any shape or geometry, and may remain in place within the three-dimensional cell growth medium.
    Type: Grant
    Filed: May 7, 2016
    Date of Patent: July 19, 2022
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Wallace Gregory Sawyer, Thomas Ettor Angelini, Steven Craig Ghivizzani, Tapomoy Bhattacharjee, Glyn Daniel Palmer
  • Publication number: 20210003528
    Abstract: Various examples are provided for disposable medical sensors that can be used for detection of SARS-CoV-2 antigen, cardiac troponin I, or other biosensing applications. In one example, a medical sensing system includes single-use disposable test strip comprising a functionalized sensing area configured to detect SARS-CoV-2 antigen and a portable sensing and readout device including pulse generation circuitry that can generate synchronized gate and drain pulses for detection and quantification of SARS-CoV-2 antigen in biological samples. In another example, a method includes providing a saliva sample to a functionalized sensing area configured to detect SARS-CoV-2 antigen, generating synchronized gate and drain pulses for a transistor, the gate pulse provided via electrodes of the functionalized sensing area, and sensing an output of the transistor that is a function of a concentration of SARS-CoV-2 antigen in the sample.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Inventors: Josephine F. Esquivel-Upshaw, Fan Ren, Stephen J. Pearton, Steven Craig Ghivizzani, Samira Afonso Camargo, Chaker Fares, Minghan Xian, Patrick H. Carey, Jenshan Lin, Siang-Sin Shan, Yu-Te Liao, Shao-Yung Lu
  • Publication number: 20180142194
    Abstract: A three-dimensional cell growth medium is described. The cell growth medium may comprise hydrogel particles swollen with a liquid cell growth medium to form a granular gel yield stress material which undergoes a phase transformation from a solid phase to a liquid-like phase when an applied stress exceeds the yield stress. Cells may be placed in the three-dimensional cell growth medium according to any shape or geometry, and may remain in place within the three-dimensional cell growth medium.
    Type: Application
    Filed: May 7, 2016
    Publication date: May 24, 2018
    Applicant: University of Florida Research Foundation, Inc.
    Inventors: WALLACE GREGORY SAWYER, THOMAS ETTOR ANGELINI, STEVEN CRAIG GHIVIZZANI, TAPOMOY BHATTACHARJEE, GLYN DANIEL PALMER
  • Publication number: 20080187576
    Abstract: Disclosed are methods and compositions for treating articular diseases such as osteoarthritis and rheumatoid arthritis, or articular dysfunction in mammals. Also disclosed are self-complimentary AAV vectors useful in gene therapy and delivery of therapeutic constructs to mammalian cells, and in particular, articular joints, cartilage, ligaments, tendons, and surrounding tissues.
    Type: Application
    Filed: June 18, 2007
    Publication date: August 7, 2008
    Applicants: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC., THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Steven Craig Ghivizzani, Christopher Howard Evans, Elvire Gouze, Jean-Noel Gouze